Related Experiment Video
Updated: Oct 22, 2025

08:21
Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
Published on: April 13, 2022
2.8K
LibINVENT: Reaction-based Generative Scaffold Decoration for in Silico Library Design
Vendy Fialková1, Jiaxi Zhao1,2, Kostas Papadopoulos1
1Molecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg 43183, Sweden.
Journal of Chemical Information and Modeling
|August 30, 2021
Summary
LibINVENT is a new drug design tool that generates focused chemical libraries for lead optimization. It rapidly proposes core-sharing compounds with desirable properties, aiding efficient drug discovery.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Drug Discovery
Background:
- Lead optimization relies on screening focused, core-sharing chemical libraries due to the structure-activity relationship.
- Existing in silico methods primarily focus on molecule generation, not focused library design.
Purpose of the Study:
- To introduce LibINVENT, a novel computational tool for de novo drug design.
- To enable the rapid generation of focused, core-sharing chemical libraries for lead optimization.
Main Methods:
- LibINVENT designs virtual chemical libraries by proposing compounds with a shared structural core.
- The tool maximizes desirable compound properties and allows user-specified synthetic reactions.
- It ensures library compounds are similar, possess desired properties, and are synthesizable under similar conditions.
Main Results:
- LibINVENT rapidly proposes chemical libraries tailored for lead optimization.
- The tool facilitates the design of focused libraries by incorporating user-defined synthetic constraints.
- Shared core structures ensure compound similarity and synthetic feasibility.
Conclusions:
- LibINVENT offers a flexible solution for generating virtual chemical libraries in drug discovery.
- The tool supports efficient lead optimization by creating focused, synthesizable compound libraries.
- LibINVENT is freely available, promoting broader accessibility in drug design research.

